CellCarta acquires Biogazelle to strengthen its genomic capabi...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MONTREAL, Dec. 14, 2021 /PRNewswire-AsiaNet/ -- -- This acquisition solidifies CellCarta's leadership position in genomic services with a unique combination of assay development and global clinical trial sample analysis capabilities covering a comprehensive range of established and cutting-edge...
Authors: LATEST ASIANET NEWS RELEASES